Search

Your search keyword '"Devesa, Susan S."' showing total 447 results
Start Over Author "Devesa, Susan S." Language english
447 results on '"Devesa, Susan S."'

9. Decreasing incidence of hepatocellular carcinoma among most racial groups: SEER‐22, 2000–2019.

Author

O'Brien, Thomas R., Devesa, Susan S., Koshiol, Jill, Marrero, Jorge A., and Shiels, Meredith S.

Subjects
*BLACK people, *ETHNIC groups, *AFRICAN Americans, *PACIFIC Islanders, *DEMOGRAPHIC characteristics
Abstract

Background: Hepatocellular carcinoma (HCC) incidence was rising in the United States. Previously, using data collected by the Surveillance, Epidemiology, and End Results (SEER) Program through 2017, we found that overall incidence had begun to decline, although not in Black and American Indian/Alaska Native (AI/AN) populations. Utilizing expanded SEER data encompassing ~50% of the population, we examined secular trends and demographic differences in HCC incidence through 2019. Methods: We included cases of HCC diagnosed in adults aged ≥20 years residing in SEER‐22 registry areas. We examined case counts, incidence rates (per 100,000 person‐years), annual percent changes (APCs), and calendar years when APCs changed significantly. Results: HCC incidence increased from 5.56 in 2000 to 8.89 in 2009 (APC, 5.17%), then rose more slowly during 2009–2015 (APC, 2.28%). After peaking at 10.03 in 2015, incidence fell to 9.20 in 2019 (APC, −2.26%). In Asian/Pacific Islanders (A/PI), the decline began in 2007 and accelerated in 2015 (APCs: 2007–2015, −1.84%; 2015–2019, −5.80%). In 2014, incidence began to fall in the White (APC: 2014–2019, −1.11%) and Hispanic populations (APC: 2014–2019, −1.72%). In 2016, rates began to fall in Black individuals (APC: 2016–2019, −6.05%). In the AI/AN population, incidence was highest in 2017, although the subsequent decline was not statistically significant. In 2019, population‐specific rates were: White, 6.94; Black, 10.74; A/PI, 12.11; AI/AN, 14.56; Hispanic, 15.48. Conclusion: HCC incidence is now decreasing in most US racial/ethnic populations, including among Black individuals. The onset of decline differed among racial/ethnic groups and wide disparities in HCC rates remain. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

10. Incidence of Burkitt lymphoma in the United States during 2000 to 2019.

Author

Mburu, Waruiru, Devesa, Susan S., Check, David, Shiels, Meredith S., and Mbulaiteye, Sam M.

Subjects
OLDER people, LYMPHOMAS, BLACK people, AGE groups, CHILD patients
Abstract

Burkitt lymphoma (BL) is an aggressive B‐cell lymphoma that occurs worldwide. A study of BL in the US National Cancer Institute's Surveillance, Epidemiology and End Results (SEER) program during 1973 to 2005 (n = 3043) revealed three age‐specific incidence peaks of BL and rates that were rising. We studied BL cases diagnosed in SEER 22 during 2000 to 2019 (n = 11 626) to investigate age‐specific BL incidence rates and temporal trends. The age‐standardized BL incidence rate was 3.96/million person‐years, with a 2.85:1 male‐to‐female ratio. The BL rate among both Hispanic and White individuals was higher than in Black individuals (4.52, 4.12 vs 3.14). Age‐specific BL rates showed peaks during pediatric, adult and elderly years in males and pediatric and elderly peaks in females. Based on 4524 BL cases with HIV status (SEER 13), only one peak in adult males (45 years) was observed. Overall age‐standardized BL incidence rates rose 1.2%/year (not significant) up to 2009 then fell significantly by 2.4%/year thereafter. Temporal trends in BL rates during 2000 to 2019 varied with age group as pediatric BL rates rose 1.1%/year, while elderly BL rates fell 1.7%/year and adult BL rates rose 3.4%/year until 2007 before falling 3.1%/year thereafter. Overall survival from BL was 64% at 2 years, being highest in pediatric patients and lowest in Black and elderly individuals vs other subgroups. Survival improved by 20% between 2000 and 2019. Our data suggest that BL age‐specific incidence rates are multimodal and that overall BL rates rose up to 2009 and then fell, suggesting changes in etiological factors or diagnosis. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

11. Geographic Patterns in U.S. Lung Cancer Mortality and Cigarette Smoking.

Author

Shreves, Alaina H., Buller, Ian D., Chase, Elizabeth, Creutzfeldt, Hannah, Fisher, Jared A., Graubard, Barry I., Hoover, Robert N., Silverman, Debra T., Devesa, Susan S., and Jones, Rena R.

Abstract

Background: Despite the success of smoking cessation campaigns, lung cancer remains the leading cause of cancer death in the U.S. Variations in smoking behavior and lung cancer mortality are evident by sex and region. Methods: Applying geospatial methods to lung cancer mortality data from the National Vital Statistics System and county-level estimates of smoking prevalences from the NCI's Small Area Estimates of Cancer-Related Measures, we evaluated patterns in lung cancer mortality rates (2005-2018) in relation to patterns in ever cigarette smoking prevalences (1997-2003). Results: Overall, ever smoking spatial patterns were generally associated with lung cancer mortality rates, which were elevated in the Appalachian region and lower in the West for both sexes. However, we also observed geographic variation in mortality rates that is not explained by smoking. Using Lee's L statistic for assessing bivariate spatial association, we identified counties where the ever smoking prevalence was low and lung cancer rates were high. We observed a significant cluster of counties (n = 25; P values ranging from 0.001 to 0.04) with low ever smoking prevalence and high mortality rates among females around the Mississippi River region south of St. Louis, Missouri and a similar and smaller cluster among males in Western Mississippi (n = 12; P values ranging from 0.002 to 0.03) that has not been previously described. Conclusions: Our analyses identified U.S. counties where factors other than smoking may be driving lung cancer mortality. Impact: These novel findings highlight areas where investigation of environmental and other risk factors for lung cancer is needed. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results